EBITDA Margin % is calculated as EBITDA divided by its Revenue. Markel Group's EBITDA for the
three
months ended in Mar. 2026 was R$-918 Mil. Markel Group's Revenue for the
three
months ended in Mar. 2026 was R$15,047 Mil. Therefore, Markel Group's EBITDA margin for the quarter that ended in Mar. 2026 was -6.10%.
Markel Group (BSP:MKLC34) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Markel Group EBITDA Margin % Related Terms
Markel Group EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Markel Group's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MKLC34 vs WRB, L, CINF: EBITDA Margin % Comparison
For the Insurance - Property & Casualty subindustry, Markel Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Markel Group EBITDA Margin % vs Insurance Industry
For the Insurance industry and Financial Services sector, Markel Group's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Markel Group's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Markel Group (BSP:MKLC34) has a EBITDA Margin % of -6.10% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Markel Group and its competitors. Over the past decade, Markel Group's EBITDA Margin % has ranged from 3.00 to 28.64. According to the industry distribution chart, Markel Group ranks #162 out of 373 companies in the Insurance industry, placing it in the top 43.4%.
Is Markel Group's EBITDA Margin % too high?
Markel Group's current EBITDA Margin % is -6.10%. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 28.64. Based on the distribution chart, Markel Group ranks #162 out of 373 companies in the Insurance industry, which is above the industry midpoint. Overall, Markel Group has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Markel Group's EBITDA Margin % compare to WRB and L?
According to the Insurance industry distribution chart, Markel Group ranks #162 out of 373 companies for EBITDA Margin %. This puts Markel Group in the upper half of its industry. The industry median EBITDA Margin % is 14.81. Historically, Markel Group's own EBITDA Margin % has ranged from 3.00 to 28.64 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for an Insurance company?
The median EBITDA Margin % among Insurance companies is 14.81, based on 373 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Markel Group and its competitors. For the Insurance industry, the median EBITDA Margin % is 14.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Markel Group's current EBITDA Margin % is -6.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Markel Group stock overvalued right now?
Based on GuruFocus' analysis, Markel Group (BSP:MKLC34) is currently considered Fairly Valued. The stock's GF Value™ is R$530.87, compared to a current price of R$493.50 — trading 7% below its estimated fair value. The current EBITDA Margin % is -6.10%. Markel Group's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Markel Group (BSP:MKLC34), the current EBITDA Margin % is -6.10% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Markel Group (BSP:MKLC34) Overvalued in 2026?
Based on GuruFocus' analysis, Markel Group stock appears to be undervalued.
The current stock price of R$493.50 is trading 7% below its estimated GF Value™ of R$530.87.
GuruFocus considers Markel Group to be Fairly Valued.
Key valuation signals for BSP:MKLC34:
EBITDA Margin %: -6.10%
GF Value™: R$530.87 vs. price of R$493.50 (7% below fair value)
No single metric tells the full story. See the BSP:MKLC34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Markel's primary business is property and casualty insurance. The company focuses primarily on specialty lines, ranging from areas such as executive liability to commercial equine insurance. The acquisition of Alterra in 2013 added substantial reinsurance operations, which now account for a little over 10% of premiums. The company uses capital generated by its insurance operations to buy noninsurance operations in diverse areas, such as bakery equipment manufacturing and residential homebuilding.
81GF Score
Get the complete analysis for BSP:MKLC34
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MKLC34 has been successfully added to your 
